บทความที่มีข้อกำหนดการเข้าถึงสาธารณะ - Andreas Schneeweissดูข้อมูลเพิ่มเติม
ไม่มีให้ใช้งานในทุกที่: 15
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results …
P Schmid, HS Rugo, S Adams, A Schneeweiss, CH Barrios, H Iwata, ...
The lancet oncology 21 (1), 44-59, 2020
ข้อกำหนด: US Department of Defense, US National Institutes of Health
The coming decade in precision oncology: six riddles
A Wahida, L Buschhorn, S Fröhling, PJ Jost, A Schneeweiss, P Lichter, ...
Nature Reviews Cancer 23 (1), 43-54, 2023
ข้อกำหนด: Federal Ministry of Education and Research, Germany
The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer
V Thewes, R Simon, M Hlevnjak, M Schlotter, P Schroeter, K Schmidt, ...
Oncogene 36 (29), 4124-4134, 2017
ข้อกำหนด: Helmholtz Association
Helical tomotherapy as a new treatment technique for whole abdominal irradiation
N Rochet, F Sterzing, A Jensen, J Dinkel, K Herfarth, K Schubert, ...
Strahlentherapie und Onkologie 184 (3), 145, 2008
ข้อกำหนด: German Research Foundation
A plasma metabolite panel as biomarkers for early primary breast cancer detection
B Yuan, S Schafferer, Q Tang, M Scheffler, J Nees, J Heil, S Schott, ...
International journal of cancer 144 (11), 2833-2842, 2019
ข้อกำหนด: Helmholtz Association
Mutational diversity and therapy response in breast cancer: A sequencing analysis in the neoadjuvant GeparSepto trial
S Loibl, D Treue, J Budczies, K Weber, A Stenzinger, WD Schmitt, ...
Clinical Cancer Research 25 (13), 3986-3995, 2019
ข้อกำหนด: Federal Ministry of Education and Research, Germany
Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer
C Peng, M Wallwiener, A Rudolph, K Ćuk, U Eilber, M Celik, C Modugno, ...
International journal of cancer 138 (10), 2499-2509, 2016
ข้อกำหนด: Helmholtz Association
Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study
N Rochet, F Sterzing, AD Jensen, J Dinkel, KK Herfarth, K Schubert, ...
International Journal of Radiation Oncology* Biology* Physics 76 (5), 1382-1389, 2010
ข้อกำหนด: German Research Foundation
Targeted next‐generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance
N Pfarr, R Penzel, V Endris, C Lier, C Flechtenmacher, AL Volckmar, ...
Genes, Chromosomes and Cancer 56 (4), 255-265, 2017
ข้อกำหนด: Federal Ministry of Education and Research, Germany
Plasma S100P level as a novel prognostic marker of metastatic breast cancer
C Peng, H Chen, M Wallwiener, C Modugno, K Cuk, D Madhavan, ...
Breast cancer research and treatment 157, 329-338, 2016
ข้อกำหนด: Helmholtz Association
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer
SF Jauch, S Riethdorf, MR Sprick, F Schütz, B Schönfisch, SY Brucker, ...
Breast Cancer Research and Treatment 173, 155-165, 2019
ข้อกำหนด: Helmholtz Association, European Commission, Federal Ministry of Education …
How the consolidated framework for implementation research can strengthen findings and improve translation of research into practice: a case study
MD Cornelia von Hagens, A Schneeweiss, M Andreas Müller MD, ...
Oncology nursing forum 44 (5), E223, 2017
ข้อกำหนด: Federal Ministry of Education and Research, Germany
Zur prognostischen Relevanz des CTC-Status bei Progress des metastasierten Mammakarzinoms
SF Jauch, S Riethdorf, MR Sprick, F Schütz, B Schönfisch, SY Brucker, ...
Senologie-Zeitschrift für Mammadiagnostik und-therapie 15 (03), 136-137, 2018
ข้อกำหนด: Helmholtz Association, Federal Ministry of Education and Research, Germany
Helical Tomotherapy as a New Treatment Technique for Whole Abdominal Irradiation.
F Sterzing, A Jensen, J Dinkel, K Herfarth, K Schubert, M Eichbaum, ...
Strahlentherapie und Onkologie 184 (3), 2008
ข้อกำหนด: German Research Foundation
Helikale Tomotherapie als neues Therapieverfahren für eine Ganzabdomenbestrahlung
N Rochet, F Sterzing, A Jensen, J Dinkel, K Herfarth, K Schubert, ...
Strahlentherapie und Onkologie 184, 145-149, 2008
ข้อกำหนด: German Research Foundation
มีให้ใช้งานในบางที่: 99
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer
SM Swain, J Baselga, SB Kim, J Ro, V Semiglazov, M Campone, ...
New England journal of medicine 372 (8), 724-734, 2015
ข้อกำหนด: US National Institutes of Health
Association analysis identifies 65 new breast cancer risk loci
K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ...
Nature 551 (7678), 92-94, 2017
ข้อกำหนด: US National Institutes of Health, Canadian Institutes of Health Research …
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353-361, 2013
ข้อกำหนด: US National Institutes of Health, Canadian Institutes of Health Research …
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
I Baccelli, A Schneeweiss, S Riethdorf, A Stenzinger, A Schillert, V Vogel, ...
Nature biotechnology 31 (6), 539-544, 2013
ข้อกำหนด: German Research Foundation
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo …
SM Swain, SB Kim, J Cortés, J Ro, V Semiglazov, M Campone, E Ciruelos, ...
The lancet oncology 14 (6), 461-471, 2013
ข้อกำหนด: US National Institutes of Health
แหล่งที่มาและข้อมูลกองทุนดำเนินการโดยโปรแกรมคอมพิวเตอร์โดยอัตโนมัติ